At the news
? BEARISHIMPACT 6/10 CLUSTER filed Apr 16, 2026 at 20:00 ET
KalVista Pharmaceuticals executives Palleiko (CEO) and Piekos (CFO) sold shares worth $231K in aggregate over a 7-day window, including open-market sales totaling $231K. The transactions follow derivative exercises, which are non-cash events.
- CEO Palleiko sold $193K of stock in open-market transactions on 2026-04-17.
- CFO Piekos sold $38K of stock in open-market transactions on 2026-04-17.
- Both executives also exercised derivatives (totaling $0 value) on 2026-04-16, which are routine non-cash events.
- Total open-market selling by insiders: $231K over 7 days.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access